1. Academic Validation
  2. FXR Regulates Intestinal Cancer Stem Cell Proliferation

FXR Regulates Intestinal Cancer Stem Cell Proliferation

  • Cell. 2019 Feb 21;176(5):1098-1112.e18. doi: 10.1016/j.cell.2019.01.036.
Ting Fu 1 Sally Coulter 2 Eiji Yoshihara 1 Tae Gyu Oh 1 Sungsoon Fang 3 Fritz Cayabyab 1 Qiyun Zhu 4 Tong Zhang 5 Mathias Leblanc 1 Sihao Liu 1 Mingxiao He 1 Wanda Waizenegger 1 Emanuel Gasser 1 Bernd Schnabl 6 Annette R Atkins 1 Ruth T Yu 1 Rob Knight 7 Christopher Liddle 2 Michael Downes 8 Ronald M Evans 9
Affiliations

Affiliations

  • 1 Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
  • 2 Storr Liver Centre, Westmead Institute for Medical Research and Sydney Medical School, University of Sydney, Westmead NSW 2145, Australia.
  • 3 Severance Biomedical Science Institute, BK21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul 03722, South Korea.
  • 4 Department of Medicine, University of California San Diego, La Jolla, CA 92037, USA.
  • 5 Waitt Biophotonics Core, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
  • 6 Department of Pediatrics, University of California San Diego, La Jolla, CA 92037, USA.
  • 7 Department of Medicine, University of California San Diego, La Jolla, CA 92037, USA; Department of Computer Science and Engineering, University of California San Diego, La Jolla, CA 92037, USA.
  • 8 Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA. Electronic address: [email protected].
  • 9 Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA. Electronic address: [email protected].
Abstract

Increased levels of intestinal bile acids (BAs) are a risk factor for colorectal Cancer (CRC). Here, we show that the convergence of dietary factors (high-fat diet) and dysregulated Wnt signaling (APC mutation) alters BA profiles to drive malignant transformations in Lgr5-expressing (Lgr5+) Cancer Stem Cells and promote an adenoma-to-adenocarcinoma progression. Mechanistically, we show that BAs that antagonize intestinal farnesoid X receptor (FXR) function, including tauro-β-muricholic acid (T-βMCA) and deoxycholic acid (DCA), induce proliferation and DNA damage in Lgr5+ cells. Conversely, selective activation of intestinal FXR can restrict abnormal Lgr5+ cell growth and curtail CRC progression. This unexpected role for FXR in coordinating intestinal self-renewal with BA levels implicates FXR as a potential therapeutic target for CRC.

Keywords

BA-FXR axis; Lgr5(+) intestinal stem cells; colon cancer progression; genetic and dietary risk factors.

Figures
Products